Format

Send to

Choose Destination
BMJ Open. 2020 Feb 2;10(1):e033002. doi: 10.1136/bmjopen-2019-033002.

Scoping review of pharmacy-based initiatives for preventing unintended pregnancy: protocol.

Author information

1
General Practice, Monash University Faculty of Medicine Nursing and Health Sciences, Notting Hill, Victoria, Australia.
2
General Practice, Monash University Faculty of Medicine Nursing and Health Sciences, Notting Hill, Victoria, Australia Danielle.Mazza@monash.edu.

Abstract

INTRODUCTION:

Due to a high global incidence of unintended pregnancy, finding novel ways to increase the accessibility of contraceptive products and information is critical. One proposed strategy is to use the accessibility of community pharmacies and expand the role of pharmacists to deliver these services. This protocol reports the methods of a proposed scoping review of pharmacy-based initiatives for preventing unintended pregnancy. We intend to identify the range of interventions employed by pharmacists worldwide and their outcomes and aim to infer the value of task sharing for reducing certain access and equity barriers to contraception.

METHODS AND ANALYSIS:

This protocol was developed with guidance from the Joanna Briggs Institute Methodology for Scoping Reviews. Reporting is compliant with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) protocols. The scoping review will be reported according to the PRISMA Extension for Scoping Reviews. Seven electronic databases (PubMed, Ovid Medline, Embase, Cochrane Library, Scopus and Cumulative Index to Nursing and Allied Health Literature) were systematically searched for relevant literature published in English from 2000, on 22 August 2019. Two authors will individually screen articles for eligibility in Covidence and data will be charted and reported using a tool developed for the purpose of this review.

ETHICS AND DISSEMINATION:

Findings will be disseminated in publications and presentations with relevant stakeholders. Ethical approval is not required as we will be using data from publicly available literature sources. We will map available evidence across the breadth of studies that have been conducted and identify the effectiveness and acceptability of interventions.

KEYWORDS:

primary care; public health; quality in health care; reproductive medicine

Conflict of interest statement

Competing interests: DM has received research funding, travel grants and honorarium from Bayer.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center